NCT05139316Phase 3Completed

A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Study sponsor: Ultragenyx Pharmaceutical Inc · RARE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-02-20Actual
Enrollment · participants52Actual
Source updated2026-10-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Percent Change from Baseline to Week 48 in Daily Cornstarch Intake Time frame: Baseline, Week 48. After: Measure: Main Study: Percent Change From Baseline to Week 48 in Daily Cornstarch Intake (Grams) Description: The least square (LS) mean and standard error (SE) are based on mixed-model for repeated measures (MMRM) analysis. Time frame: Baseline, Weeks 24, 30, 36, 42 and 48 Measure: Japan Cohort: Percent Change From Baseline to Week 48 in Daily Cornstarch Intake (Grams) Time frame: Baseline, Weeks 24, 30, 36, 42 and 48.

Actual enrollment increased by 3 participants

Before: 49 participants (actual). After: 52 participants (actual).

Check registry source

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview